FOR IMMEDIATE RELEASE
Contact: Murray Penner
July 29, 2013, Washington, DC – As part of ongoing efforts by the ADAP Crisis Task Force (Task Force) and the pharmaceutical industry to address the continued need for access to HIV antiretroviral medicines through AIDS Drug Assistance Programs (ADAPs), the Task Force announced today that it has reached agreement with AbbVie, Gilead Sciences, Merck, and ViiV Healthcare to extend the voluntary discounts/rebates and price freezes available to all state ADAPs through December 31, 2014.
By Meico Whitlock, Senior Manager, Communications, NASTAD
In May at our 22nd Annual Meeting of state health department HIV and hepatitis program leaders in Washington, D.C., we had an opportunity to hear from federal and state leaders about Affordable Care Act (ACA) Implementation and its impact on HIV/AIDS and viral hepatitis program providers. Below is an interview with Amy Killelea, Senior Manager, Health Care Access at NASTAD and Maria Courogen, Director of Infectious Disease and Reproductive Health at the Washington State Department of Health who shared their highlights of the discussion. Continue reading
By Kathleen Sebelius, Secretary of Health and Human Services and Valerie Jarrett, Senior Advisor to the President
Cross-posted from AIDS.gov
Three years ago, President Obama announced an historic comprehensive plan to help turn the tide on HIV/AIDS in the United States: the National HIV/AIDS Strategy. The Strategy has given a new sense of direction, and purpose in our fight against HIV and AIDS.
Since the Strategy’s release, scientific developments have advanced our understanding of how to best fight HIV. We now understand that to prevent long-term complications of HIV, treatment is recommended for all adults and adolescents living with HIV in the United States. Continue reading
By Andrew D. Forsyth, Ph.D., Senior Science Advisor, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services and Ronald Valdiserri, M.D., M.P.H., Deputy Assistant Secretary for Health, Infectious Diseases, and Director, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services
Cross-posted from AIDS.gov
The Department of Health and Human Services (HHS) recently reached a significant
milestone in our ongoing efforts to standardize and streamline data collection for recipients of federal HIV funds. On June 28, 2013, Secretary of Health and Human Kathleen Sebelius approved plans submitted by nine HHS operating divisions and staff offices to adopt and deploy common core indicators for monitoring HHS-funded HIV prevention, treatment, and care services and to streamline data collection for HIV services grantees. This approval was the outcome of two years of cross-agency work to respond to the National HIV/AIDS Strategy’s call to standardize data collection and reduce grantee reporting requirements. The Secretary’s approval of these plans paves the way for their implementation in Fiscal Year 2014, beginning on October 1, 2013. This first step to reduce grantee reporting burden will enable HIV grantees to focus more time and attention on providing high quality HIV prevention, treatment, and care services. Continue reading
By Amy Killelea, Senior Manager, Health Care Access, NASTAD
HIV/AIDS disproportionately impacts gay men and other men who have sex with men (MSM), particularly gay men/MSM of color, in the form of higher infection rates, less likelihood of timely linkage to care, and less likelihood of viral suppression. To make headway against the epidemic and to meet the goals of the National HIV/AIDS Strategy (NHAS), we need tools and strategies that are aimed at improving prevention, access to care, and retention in care for gay men/MSM.